Zobrazeno 1 - 10 of 102 pro vyhledávání: '"N Ringdal"'
1
Akademický článek
A blinded comparison of fluticasone propionate with budesonide via powder devices in adult patients with moderate-to-severe asthma: a clinical evaluation
Autor: N. Ringdal, P. Swinburn, R. Backman, P. Plaschke, A. P. Sips, P. Kjaersgaard, G. Bratten, T. A. J. Harris
Publikováno v: Mediators of Inflammation, Vol 5, Iss 5, Pp 382-389 (1996)
In Vitro and in vivo data have demonstrated that there are detectable differences between inhaled corticosteroids commonly used to treat asthma. However, controversy still remains as to whether these differences translate into clinical benefits. This
Externí odkaz: https://doaj.org/article/4fb21dc819af40eaba5432e61aa9de99
Zobrazit plný text záznamu
2
Akademický článek
A associação salmeterol//fluticasona é mais eficaz do que a fluticasona e o montelukast oral na asma
Autor: N. Ringdal, A. Eliraz, P. Pruzinec, H.H. Weber, P.G.H. Mulder, M. Akeveld, E.D. Bateman
Publikováno v: Revista Portuguesa de Pneumologia, Vol 10, Iss 2, Pp 181-183 (2004)
RESUMO: Em todo o mundo, as taxas de morbilidade e mortalidade relacionadas com a asma têm vindo a aumentar. Segundo as normas intervencionais (Guidelines), os objectivos do manejamento da asma brônquica devem ser o controlo de sintomas e a pre
Externí odkaz: https://doaj.org/article/d6011487d8e5479887565489af90fbfc
Zobrazit plný text záznamu
3
Evaluation of different inhaled combination therapies (EDICT): a randomised, double-blind comparison of SeretideTM (50/250 μg bd DiskusTM vs. formoterol (12 μg bd) and budesonide (800 μg bd) given concurrently (both via TurbuhalerTM) in patients with moderate-to-severe asthma
Autor: A Chuchalin, Philip J. Whitehead, L Chovan, N Tudoric, N Ringdal, Enrico Maggi
Publikováno v: Respiratory Medicine. 96:851-861
The aim of this study was to compare the efficacy safety and cost of Seretide (salmeterol/fluticasone propionate (Salm/FP), 50/250 microg bd) via Diskus with formoterol (Form; 12 microg bd) and budesonide (Bud; 800 microg bd) given concurrently (Form
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0c7b3f9d4669e41793f85252c7e9f77
https://doi.org/10.1053/rmed.2002.1416
Zobrazit plný text záznamu
5
Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients
Autor: S. Rak, G. Bratten, N. Ringdal, P. Kjaersgaard, M. Alton, A. Eivindson, Bo Lundbäck
Publikováno v: Respiratory Medicine. 94(5):482-489
This randomized, double-blind, double-dummy, multicentre cross-over study compared the effects on the hypothalamic-pituitary-adrenal (HPA) axis of fluticasone propionate (750 microg twice daily given via the Diskus) and budesonide (800 microg twice d
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3d2a665111fb2ed56c03d91d4722956
Zobrazit plný text záznamu
6
Low-dose formoterol Turbuhaler® (Oxis®) b.i.d., a 3-month placebo-controlled comparison with terbutaline (q.i.d.)
Autor: N. Ringdal, V. Sobradillo, T. Ekström, E. Runnerström, S. Soliman
Publikováno v: Respiratory Medicine. 92(8):1040-1045
This study compared the efficacy of a low dose of formoterol Turbuhaler® 6 μg b.i.d. (F) with that of terbutaline 0·5 mg q.i.d. (T), and placebo (P) from Turbuhaler®. After a 2-week run-in, 397 adults with mild to moderate asthma were randomly al
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08eae681f312e89a5641363ca2c6e86c
Zobrazit plný text záznamu
7
Onset and duration of action of single doses of formoterol inhaled via turbuhaler®
Autor: Elisabeth Wahlin-Boll, Romain Pauwels, Eric Derom, N. Ringdal
Publikováno v: Respiratory Medicine. 92(8):1017-1021
The aim of the study was to investigate the time of onset and the duration of the bronchodilating effect of different doses of formoterol administered via Turbuhaler in patients with moderate asthma. Thirty-one patients (five women) with a mean force
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1e5812c232db87476c09c3cb13aac95
Zobrazit plný text záznamu
9
Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids
Autor: B Lundback, N Ringdal, L A Jacques, A Woolcock
Publikováno v: American Journal of Respiratory and Critical Care Medicine. 153:1481-1488
A study was done to compare the efficacy and safety of the coprescription of salmeterol 50 microgram twice daily or 100 microgram twice daily with beclomethasone dipropionate (BDP) 500 micrograms twice daily (SALM 50 and SALM 100) with BDP 1,000 micr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c4ebd36df7e96e2c12db4ffb16463e1
https://doi.org/10.1164/ajrccm.153.5.8630590
Zobrazit plný text záznamu
10
A blinded comparison of fluticasone propionate with budesonide via powder devices in adult patients with moderate-to-severe asthma: a clinical evaluation
Autor: R. Backman, P. Plaschke, P. Swinburn, P. Kjaersgaard, T. A. J. Harris, N. Ringdal, A. P. Sips, G. Bratten
Publikováno v: Mediators of Inflammation
Mediators of Inflammation, Vol 5, Iss 5, Pp 382-389 (1996)
In Vitro and in vivo data have demonstrated that there are detectable differences between inhaled corticosteroids commonly used to treat asthma. However, controversy still remains as to whether these differences translate into clinical benefits. This
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48abbf2bc6009acfd806e7cb6e049126
https://doi.org/10.1155/s0962935196000555
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje